• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Danaher Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    5/8/25 4:36:17 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials
    Get the next $DHR alert in real time by email
    dhr-20250506
    False000031361600003136162025-05-062025-05-060000313616us-gaap:CommonStockMember2025-05-062025-05-060000313616dhr:A0.2SeniorNotesDue2026Member2025-05-062025-05-060000313616dhr:A2.1SeniorNotesDue2026Member2025-05-062025-05-060000313616dhr:A1.2SeniorNotesDue2027Member2025-05-062025-05-060000313616dhr:A0.45SeniorNotesDue2028Member2025-05-062025-05-060000313616dhr:A2.5SeniorNotesDue2030Member2025-05-062025-05-060000313616dhr:A0.75SeniorNotesDue2031Member2025-05-062025-05-060000313616dhr:A1.35SeniorNotesDue2039Member2025-05-062025-05-060000313616dhr:A1.8SeniorNotesDue2049Member2025-05-062025-05-06

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    __________________
    FORM 8-K
    __________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934
    Date of report (Date of earliest event reported): May 6, 2025
    __________________
    dhrlogo.jpg
    DANAHER CORPORATION
    (Exact Name of Registrant as Specified in Its Charter)
    __________________
    Delaware001-0808959-1995548
    (State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
    2200 Pennsylvania Avenue, N.W., 20037-1701
    Suite 800W
    Washington,DC
    (Address of Principal Executive Offices) (Zip Code)
    202-828-0850
    (Registrant’s Telephone Number, Including Area Code)
    Not applicable
    (Former Name or Former Address, if Changed Since Last Report)
    __________________
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common stock, $0.01 par valueDHRNew York Stock Exchange
    0.200% Senior Notes due 2026DHR/26New York Stock Exchange
    2.100% Senior Notes due 2026DHR 26New York Stock Exchange
    1.200% Senior Notes due 2027DHR/27New York Stock Exchange
    0.450% Senior Notes due 2028DHR/28New York Stock Exchange
    2.500% Senior Notes due 2030DHR 30New York Stock Exchange
    0.750% Senior Notes due 2031DHR/31New York Stock Exchange
    1.350% Senior Notes due 2039DHR/39New York Stock Exchange
    1.800% Senior Notes due 2049DHR/49New York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 



    ITEM 5.07SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
    The annual meeting of shareholders of Danaher Corporation (the “Company”) was held on May 6, 2025. At the annual meeting, the Company’s shareholders voted on the following proposals:
    1.    To elect the thirteen directors named in the Company’s proxy statement to terms expiring in 2026. Each nominee for director was elected by a vote of the shareholders as follows:
    ForAgainstAbstainBroker Non-Votes
    Rainer M. Blair587,708,832 8,022,344 752,614 34,398,729 
    Feroz Dewan573,310,308 22,006,783 1,166,699 34,398,729 
    Linda Filler521,091,800 72,692,479 2,699,511 34,398,729 
    Charles W. Lamanna592,942,051 2,783,910 757,829 34,398,729 
    Teri List462,328,466 133,272,899 882,425 34,398,729 
    Jessica L. Mega, MD, MPH586,943,763 8,795,319 744,708 34,398,729 
    Mitchell P. Rales583,721,901 11,849,664 912,225 34,398,729 
    Steven M. Rales570,976,784 24,753,826 753,180 34,398,729 
    A. Shane Sanders446,667,687 148,778,691 1,037,412 34,398,729 
    John T. Schwieters419,939,600 175,342,479 1,201,711 34,398,729 
    Alan G. Spoon548,616,426 47,105,789 761,575 34,398,729 
    Raymond C. Stevens, PhD470,315,717 125,252,620 915,453 34,398,729 
    Elias A. Zerhouni, MD562,772,475 32,537,885 1,173,430 34,398,729 
    2.    To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025. The proposal was approved by a vote of shareholders as follows:
    For599,098,858 
    Against30,778,244 
    Abstain1,005,417 
    3.    To approve on an advisory basis the Company’s named executive officer compensation. The proposal was approved by a vote of shareholders as follows:
    For562,800,461 
    Against30,795,342 
    Abstain2,887,987 
    Broker Non-Votes 34,398,729 

    ITEM 9.01FINANCIAL STATEMENTS AND EXHIBITS
    (c)Exhibits:
    Exhibit No.Description
    104Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)




    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    DANAHER CORPORATION
    Date:May 8, 2025By:/s/ James F. O'Reilly
    James F. O'Reilly
    Senior Vice President, Deputy General Counsel and Secretary; Chief Sustainability Officer


    Get the next $DHR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DHR

    DatePrice TargetRatingAnalyst
    4/10/2025$205.00Equal Weight → Overweight
    Barclays
    3/21/2025$260.00Neutral → Buy
    Goldman
    3/14/2025$260.00Hold → Buy
    Stifel
    2/3/2025Outperform → Mkt Perform
    Raymond James
    12/23/2024Sector Perform
    Scotiabank
    12/19/2024$275.00Buy
    Guggenheim
    12/13/2024$290.00Neutral → Buy
    BofA Securities
    10/31/2024$285.00Peer Perform → Outperform
    Wolfe Research
    More analyst ratings

    $DHR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Executive Vice President Riley Christopher Paul exercised 7,801 shares at a strike of $76.47 and sold $3,129,424 worth of shares (15,805 units at $198.00), decreasing direct ownership by 35% to 15,179 units (SEC Form 4)

      4 - DANAHER CORP /DE/ (0000313616) (Issuer)

      5/1/25 5:01:19 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • SEC Form 4 filed by Director Filler Linda

      4 - DANAHER CORP /DE/ (0000313616) (Issuer)

      4/29/25 5:01:15 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • SEC Form 4 filed by Director Dewan Feroz

      4 - DANAHER CORP /DE/ (0000313616) (Issuer)

      4/29/25 5:01:27 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials

    $DHR
    SEC Filings

    See more
    • Danaher Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - DANAHER CORP /DE/ (0000313616) (Filer)

      5/8/25 4:36:17 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Danaher Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - DANAHER CORP /DE/ (0000313616) (Filer)

      4/22/25 6:08:20 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • SEC Form 10-Q filed by Danaher Corporation

      10-Q - DANAHER CORP /DE/ (0000313616) (Filer)

      4/22/25 6:03:03 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials

    $DHR
    Financials

    Live finance-specific insights

    See more
    • Danaher Announces Quarterly Dividend

      WASHINGTON, May 6, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on July 25, 2025 to holders of record on June 27, 2025. ABOUT DANAHERDanaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and h

      5/6/25 4:15:00 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Danaher Reports First Quarter 2025 Results

      WASHINGTON, April 22, 2025 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) (the "Company") today announced results for the quarter ended March 28, 2025. Key First Quarter 2025 Results Net earnings were $1.0 billion, or $1.32 per diluted common share and non-GAAP adjusted diluted net earnings per common share were $1.88.Revenues decreased 1.0% to $5.7 billion and non-GAAP core revenue was flat year-over-year.Operating cash flow was $1.3 billion and non-GAAP free cash flow was $1.1 billion.Rainer M. Blair, President and Chief Executive Officer, stated, "Revenue, earnings, and cash flow exceeded our expectations in the first quarter–highlighted by continued momentum in bioprocessing and better-

      4/22/25 6:00:00 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Danaher Schedules First Quarter 2025 Earnings Conference Call

      WASHINGTON, March 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2025 on Tuesday, April 22, 2025 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call. You

      3/20/25 4:15:00 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials

    $DHR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Danaher upgraded by Barclays with a new price target

      Barclays upgraded Danaher from Equal Weight to Overweight and set a new price target of $205.00

      4/10/25 8:28:29 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Danaher upgraded by Goldman with a new price target

      Goldman upgraded Danaher from Neutral to Buy and set a new price target of $260.00

      3/21/25 8:01:35 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Danaher upgraded by Stifel with a new price target

      Stifel upgraded Danaher from Hold to Buy and set a new price target of $260.00

      3/14/25 7:34:47 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials

    $DHR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Danaher Corporation (Amendment)

      SC 13G/A - DANAHER CORP /DE/ (0000313616) (Subject)

      2/9/23 11:16:32 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Danaher Corporation (Amendment)

      SC 13G/A - DANAHER CORP /DE/ (0000313616) (Subject)

      2/9/22 3:43:35 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13D/A filed by Danaher Corporation (Amendment)

      SC 13D/A - DANAHER CORP /DE/ (0000313616) (Subject)

      11/2/21 9:29:29 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials

    $DHR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Danaher to Present at Bank of America Securities Healthcare Conference

      WASHINGTON, May 7, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Thursday, May 15, 2025 at 10:00 a.m. PT. The event will be simultaneously webcast on www.danaher.com. ABOUT DANAHERDanaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology

      5/7/25 4:15:00 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Danaher Announces Quarterly Dividend

      WASHINGTON, May 6, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on July 25, 2025 to holders of record on June 27, 2025. ABOUT DANAHERDanaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and h

      5/6/25 4:15:00 PM ET
      $DHR
      Industrial Machinery/Components
      Industrials
    • Danaher Reports First Quarter 2025 Results

      WASHINGTON, April 22, 2025 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) (the "Company") today announced results for the quarter ended March 28, 2025. Key First Quarter 2025 Results Net earnings were $1.0 billion, or $1.32 per diluted common share and non-GAAP adjusted diluted net earnings per common share were $1.88.Revenues decreased 1.0% to $5.7 billion and non-GAAP core revenue was flat year-over-year.Operating cash flow was $1.3 billion and non-GAAP free cash flow was $1.1 billion.Rainer M. Blair, President and Chief Executive Officer, stated, "Revenue, earnings, and cash flow exceeded our expectations in the first quarter–highlighted by continued momentum in bioprocessing and better-

      4/22/25 6:00:00 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials

    $DHR
    Leadership Updates

    Live Leadership Updates

    See more
    • Danaher Announces Appointment of Charles Lamanna to Danaher Board

      WASHINGTON, Feb. 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced today that it has appointed Charles Lamanna to its Board of Directors and to the Board's Science & Technology Committee. Mr. Lamanna is currently Corporate Vice President, Business & Industry Copilot at Microsoft (NASDAQ:MSFT), where he drives product innovation in AI-powered business applications, low-code platforms, and autonomous agents. He oversees the design, product development, and engineering of some of Microsoft's most transformative technologies, including Power Platform, Dynamics 365, and Copilot Studio. Prior to that, Mr. Lamanna was the founder and CEO of MetricsHub, one of the first public cloud

      2/20/25 4:45:00 PM ET
      $DHR
      $MSFT
      Industrial Machinery/Components
      Industrials
      Computer Software: Prepackaged Software
      Technology
    • Compass Minerals Announces Senior Leadership Team Appointments

      Patrick Merrin named Chief Operations Officer and Peter Fjellman named Chief Financial Officer Compass Minerals (NYSE:CMP), a leading global provider of essential minerals, today announced the appointment of Patrick Merrin, a seasoned operating executive in the mining industry, as the company's new chief operations officer (COO) and Peter Fjellman, who has decades of experience in senior finance roles, as its new chief financial officer (CFO). Merrin's appointment is effective March 3 and fills the COO position which has been open since June 2024. Fjellman, whose appointment is effective immediately, succeeds Jeff Cathey who has decided to depart Compass Minerals due to personal reasons.

      1/28/25 6:50:00 AM ET
      $CMP
      $DHR
      $GXO
      $XPO
      Mining & Quarrying of Nonmetallic Minerals (No Fuels)
      Industrials
      Industrial Machinery/Components
      Transportation Services
    • Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development

      DH Diagnostics LLC Centers aim to accelerate drug development by speeding and streamlining development and commercialization of companion diagnostics.Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP)-certified laboratories will bring technologies and assays from multiple Danaher subsidiaries together under a single roof.WASHINGTON, July 17, 2024 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher"), a global science and technology innovator, announced the launch of two new Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP)-certified labs intended to accelerate the development of Companion Diagnostics (C

      7/17/24 7:30:00 AM ET
      $DHR
      Industrial Machinery/Components
      Industrials